Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments

Brain Research

Volumn 1007, Issue 1-2, 2004, Pages 57-64

  Gómez Ramos, Alberto ^a   Abad, Xabier ^b   Fanarraga, Mónica López ^b   Bhat, Ratan ^c   Zabala, Juan Carlos ^b   Avila, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Baculovirus; Degenerative disease: Alzheimer's miscellaneous; Disorders of the nervous system; GSK3; Tau filament; Tauopathy

Indexed keywords

POLYMER; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; MUTATION; NONHUMAN; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; BACULOVIRIDAE; BLOTTING, WESTERN; CELL LINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; INSECTS; LITHIUM; MICROFILAMENTS; MICROSCOPY, IMMUNOELECTRON; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEUROFIBRILLARY TANGLES; OVARY; PHOSPHORYLATION; TAU PROTEINS; TRANSFECTION;

EID: 1942439055     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.01.071     Document Type: Article

References (29)

1. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., Atzori C., Migheli A., Crowther R.A., Ghetti B., Spillantini M.G., Goedert M. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22:2002;9340-9351.
2. Alvarez G., Muñoz-Montaño J.R., Satrústegui J., Avila J., Bogonez E., Díaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 453:1999;260-264.
3. Baas P.W., Pienkowski T.P., Kosik K.S. Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization. J. Cell Biol. 115:1991;1333-1344.
4. Baas P.W., Pienkowski T.P., Cimbalnik K.A., Toyama K., Bakalis S., Ahmad F.J., Kosik K.S. Tau confers drug stability but not cold stability to microtubules in living cells. J. Cell. Sci. 107:1994;135-143.
5. Bhat R., Xue Y., Berg S., Hellberg S., Ormo M., Nilsson Y., Radesater A.C., Jerning E., Markgren P.O., Borgegard T., Nylof M., Gimenez-Cassina A., Hernandez F., Lucas J.J., Diaz-Nido J., Avila J. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J. Biol. Chem. 278:2003;45937-45945.
6. Biernat J., Mandelkow E.M. The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol. Biol. Cell. 10:1999;727-740.
7. Biernat J., Mandelkow E.M., Schroter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H., Mercken M., Vandermeeren A., Goedert M.et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11:1992;1593-1597.
8. Ditella M.C., Feiguin F., Carri N., Kosik K.S., Caceres A. MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth. J. Cell. Sci. 109:1996;467-477.
9. Frappier T.F., Georgieff I.S., Brown K., Shelanski M.L. Tau regulation of microtubule-microtubule spacing and bundling. J. Neurochem. 63:1994;2288-2294.
10. Frappier T., Liang N.S., Brown K., Leung C.L., Lynch T., Liem R.H.K., Shelanski M.L. Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation. FEBS Lett. 455:1999;262-266.
11. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
12. Goedert M., Jakes R., Crowther R.A., Cohen P., Vanmechelen E., Vandermeeren M., Cras P. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301(Pt. 3):1994;871-877.
13. Goedert M., Spillantini M.G., Davies S.W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8:1998;619-632.
14. Goedert M., Satumtira S., Jakes R., Smith M.J., Kamibayashi C., White C.L. III, Sontag E. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. J. Neurochem. 75:2000;2155-2162.
15. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5827-5831.
16. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 83:1986;4913-4917.
17. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T., Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature. 369:1994;488-491.
18. Hasegawa M., Morishima K.M., Takio K., Suzuki M., Titani K., Ihara Y. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J. Biol. Chem. 267:1992;17047-17054.
19. Kanai Y., Takemura R., Oshima T., Mori H., Ihara Y., Yanagisawa M., Masaki T., Hirokawa N. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J. Cell Biol. 109:1989;1173-1184.
20. Knops J., Kosik K.S., Lee G., Pardee J.D., Cohen-Gould L., McConlogue L. Overexpression of tau in a nonneuronal cell induces long cellular processes. J. Cell Biol. 114:1991;725-733.
21. Kuriyama R., Dragas-Granoic S., Maekawa T., Vassilev A., Khodjakov A., Kobayashi H. Heterogeneity and microtubule interaction of the CHO1 antigen, a mitosis-specific kinesin-like protein. Analysis of subdomains expressed in insect Sf9 cells. J. Cell. Sci. 107:1994;3485-3499.
22. Lee V.M., Trojanowski J.Q. The disordered neuronal cytoskeleton in Alzheimer's disease. Curr. Opin. Neurobiol. 2:1992;653-656.
23. Lim F., Hernandez F., Lucas J.J., Gomez-Ramos P., Moran M.A., Avila J. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell. Neurosci. 18:2001;702-714.
24. Mailliot C., Bussiere T., CailletBoudin M.L., Delacourte A., Buee L. Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation. Neurosci. Lett. 255:1998;13-16.
25. Medina M., Montejo de Garcini E., Avila J. The role of tau phosphorylation in transfected COS-1 cells. Mol. Cell. Biochem. 148:1995;79-88.
26. Munoz-Montano J.R., Moreno F.J., Avila J., Diaz-Nido J. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411:1997;183-188.
27. Reynolds C.H., Betts J.C., Blackstock W.P., Nebreda A.R., Anderton B.H. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74:2000;1587-1595.
28. Sperber B.R., Leight S., Goedert M., Lee V.M.Y. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci. Lett. 197:1995;149-153.
29. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. TINS. 21:1998;428-433.